Clinical Trials on Nerve Block in New Zealand

Total 1796 results

Salus University

Not yet recruiting

Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma (NTG)

Normal Tension Glaucoma

United States
State University of New York at Buffalo

Completed

Prediction of ARrhythmic Events With Positron Emission Tomography (PAREPET)

Ischemic Cardiomyopathy | Hibernating Myocardium | Nerve; Disorder, Sympathetic

United States
Philip Friedlander
Genentech, Inc.

Terminated

The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma

Melanoma

United States
Memorial Sloan Kettering Cancer Center
Novartis; National Comprehensive Cancer Network

Completed

Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation

Melanoma

United States
NYU Langone Health

Terminated

A Phase 1b Study of the Selective HDAC Inhibitor Mocetinostat in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma

Melanoma

United States
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb

Completed

Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity

Melanoma

United States
Genta Incorporated

Unknown

Abraxane and Temodar Plus Genasense in Advanced Melanoma

Melanoma

United States
Parker Institute for Cancer Immunotherapy
Seres Therapeutics, Inc.

Completed

Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention (MCGRAW)

Metastatic Melanoma

United States
Memorial Sloan Kettering Cancer Center

Recruiting

The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)

Chemotherapy-induced Peripheral Neuropathy | Nerve Pain

United States
Bristol-Myers Squibb

Withdrawn

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Melanoma

United States
NYU Langone Health
Novartis

Withdrawn

Trial of IDH305 in IDH1 Mutant Grade II or III Glioma

Glioma

United States
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)

Completed

Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines

Melanoma | Skin

United States
Medtronic Cardiac Rhythm and Heart Failure

Completed

SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction (SAVEPACe)

Atrial Fibrillation | Bradycardia | Ventricular Dysfunction | Heart Failure, Congestive | Sick Sinus Syndrome

United States, Canada
NYU Langone Health

Terminated

Image Guided Therapy in the Treatment of Gliomas

Glioma

United States
Bristol-Myers Squibb

Completed

Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States

Melanoma

United States
Columbia University
Pfizer

Recruiting

Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Ludwig Institute for Cancer Research
Cancer Research Institute (CRI)

Completed

NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)

Malignant Melanoma

United States
Nicholas Gulati

Completed

DPCP to Treat Cutaneous Neurofibromas Associated With NF1

Cutaneous Neurofibroma

United States
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Glioma

United States
LivaNova

Completed

Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease

Sinus Node Dysfunction | Brady Tachy Syndrome

United States, France, Belgium, Germany, United Kingdom, Italy, Monaco, Spain
Celgene
NYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.

Completed

Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab

Malignant Melanoma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Withdrawn

Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Astellas Pharma Inc
OSI Pharmaceuticals; Cell Pathways

Terminated

CP-461 in the Treatment of Patients With Advanced Melanoma

Malignant Melanoma

United States
Memorial Sloan Kettering Cancer Center
Yale University; University of New Mexico

Completed

Differential Risks for Melanoma: p16 and DNA Repair

Melanoma | Skin Melanoma

United States
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center

Completed

Study of gp75 Vaccine in Patients With Stage III and IV Melanoma

Malignant Melanoma

United States
Rowan University
American Osteopathic Association

Completed

Cost Effectiveness of OMT for Chronic Low Back Pain

Lumbar Spinal Stenosis | Lumbar Radiculopathy | Lumbar Spondylosis | Lesion of Sciatic Nerve, Left Lower Limb | Lesion of Sciatic Nerve, Right Lower Limb | Lumbago With Sciatica, Left Side | Lumbago With Sciatica, Right Side

United States
Bristol-Myers Squibb

Completed

A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US

Melanoma

United States
Bristol-Myers Squibb

Active, not recruiting

A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)

Melanoma

United States
Dartmouth-Hitchcock Medical Center

Completed

Skin Care Behaviors Among Melanoma Survivors and Their Families

Melanoma

United States
Ochsner Health System
NewLink Genetics Corporation

Unknown

A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma

Melanoma

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Massachusetts General Hospital; Washington University School of Medicine; Gla... and other collaborators

Completed

Concentration and Activity of Lapatinib in Vestibular Schwannomas

Neurofibromatosis 2 | Vestibular Schwannoma | Acoustic Neuroma | NF2 | Auditory Tumor

United States
Antonio Fojo
Ipsen

Recruiting

LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) (LAMPARA)

Pheochromocytoma | Paraganglioma

United States
NYU Langone Health

Terminated

Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma

Metastatic Melanoma

United States
Columbia University

Terminated

Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate Surgery

Prostate Cancer | Nerve Sparing Prostatectomy

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma

Melanoma (Skin)

United States
New Mexico Cancer Care Alliance

Completed

The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure

Melanoma

United States
MELA Sciences, Inc.

Completed

Does the Aid of MelaFind Affect Clinical Management Decisions

Melanoma

United States
Weill Medical College of Cornell University

Recruiting

A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging

Glioblastoma

United States
Columbia University
Merck Sharp & Dohme LLC

Terminated

MRI and PET to Assess Pembrolizumab Response (MPAK)

Malignant Melanoma, Metastatic

United States
Bristol-Myers Squibb
Medarex; Ono Pharma USA Inc

Completed

Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

Malignant Melanoma

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Bristol-Myers Squibb

Active, not recruiting

Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery

Melanoma (Skin)

United States
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Novartis; Dana-Farber Cancer Institute

Completed

A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors

Neuroendocrine Tumors

United States
Memorial Sloan Kettering Cancer Center

Completed

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

Melanoma | Survivors | Psychological Factors

United States
EpiCept Corporation

Completed

A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)

Neuropathy | Nerve Pain | Post Herpetic Neuralgia | PHN

India
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

Melanoma | Breast Cancer

United States, Germany
Weill Medical College of Cornell University
Novartis Pharmaceuticals

Recruiting

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. (DOMINO-START)

Pituitary Adenoma | Medulloblastoma | Meningioma | Esthesioneuroblastoma | Paraganglioma | CNS Tumors | Hemangioblastoma

United States
Memorial Sloan Kettering Cancer Center

Withdrawn

Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma

Glioblastoma

United States
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Completed

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Glioblastoma

United States
Ipsen

Completed

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

United States
University of Rochester

Recruiting

Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma

Glioma

United States

Clinical Trials on Nerve Block in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations